AU665762B2 - Liposomal polysaccharide vaccines - Google Patents

Liposomal polysaccharide vaccines Download PDF

Info

Publication number
AU665762B2
AU665762B2 AU19029/92A AU1902992A AU665762B2 AU 665762 B2 AU665762 B2 AU 665762B2 AU 19029/92 A AU19029/92 A AU 19029/92A AU 1902992 A AU1902992 A AU 1902992A AU 665762 B2 AU665762 B2 AU 665762B2
Authority
AU
Australia
Prior art keywords
adjuvant
antigen
liposome
composition
levan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19029/92A
Other languages
English (en)
Other versions
AU1902992A (en
Inventor
Edward Abraham
Yi-Han Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU1902992A publication Critical patent/AU1902992A/en
Application granted granted Critical
Publication of AU665762B2 publication Critical patent/AU665762B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU19029/92A 1991-05-13 1992-05-13 Liposomal polysaccharide vaccines Ceased AU665762B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69914491A 1991-05-13 1991-05-13
US699144 1991-05-13
PCT/US1992/004055 WO1992020370A1 (en) 1991-05-13 1992-05-13 Liposomal polysaccharide vaccines

Publications (2)

Publication Number Publication Date
AU1902992A AU1902992A (en) 1992-12-30
AU665762B2 true AU665762B2 (en) 1996-01-18

Family

ID=24808131

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19029/92A Ceased AU665762B2 (en) 1991-05-13 1992-05-13 Liposomal polysaccharide vaccines

Country Status (8)

Country Link
EP (1) EP0584212A4 (hu)
JP (1) JPH07500813A (hu)
AU (1) AU665762B2 (hu)
CA (1) CA2109316A1 (hu)
FI (1) FI934866A (hu)
HU (1) HUT67159A (hu)
NO (1) NO934106L (hu)
WO (1) WO1992020370A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2180576T3 (es) * 1993-04-27 2003-02-16 United Biomedical Inc Construcciones peptidicas de lhrh inmunogenicas y estimuladores de inmunidad universales sinteticos para vacunas.
FR2716373B1 (fr) * 1994-02-23 1996-05-03 Pasteur Institut Liposomes, et leur utilisation pour l'obtention de vaccins.
EP0969826A1 (en) * 1997-03-11 2000-01-12 Stichting Dienst Landbouwkundig Onderzoek Use of liposomes containing a chelating agent, a fungicide or a secropine for improving mucosal vaccination
US6749831B1 (en) 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
US7534442B2 (en) 2001-08-21 2009-05-19 The Brigham And Women's Hospital, Inc. Immunogenic compositions comprising covalently bound polysaccharides, antigen, and bacterial toxoid
EP1928418B1 (en) 2005-09-30 2011-12-21 Lipoxen Technologies Limited Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
GB2548848A (en) * 2016-03-30 2017-10-04 The Inst Of Food Res Levan polysaccharide to modulate cell function

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199565A (en) * 1979-03-26 1980-04-22 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
JP3485184B2 (ja) * 1989-07-14 2004-01-13 アメリカン サイアナミド カンパニー インターロイキン含有安定ワクチン組成物

Also Published As

Publication number Publication date
HU9303207D0 (en) 1994-03-28
WO1992020370A1 (en) 1992-11-26
HUT67159A (en) 1995-02-28
EP0584212A4 (en) 1994-11-30
EP0584212A1 (en) 1994-03-02
AU1902992A (en) 1992-12-30
CA2109316A1 (en) 1992-11-14
FI934866A0 (fi) 1993-11-03
NO934106L (no) 1994-01-12
NO934106D0 (no) 1993-11-12
FI934866A (fi) 1993-11-12
JPH07500813A (ja) 1995-01-26

Similar Documents

Publication Publication Date Title
Abraham et al. Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response.
Abraham Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmonary secretory antibody response
US9962434B2 (en) Compositions and methods for treatment of microbial infections
Shahin et al. Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly (DL-lactide-co-glycolide) microspheres
JP2005514388A (ja) グラム陰性菌由来の外膜小胞およびワクチンとしての使用
US20050260225A1 (en) Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
US6342231B1 (en) Haemophilus parasuis vaccine and diagnostic
AU665762B2 (en) Liposomal polysaccharide vaccines
JP5279497B2 (ja) 多糖抗原及びタンパク質アジュバントを含むリポソームワクチン組成物
US5013555A (en) Agent for desensitizing man and/or animals against an allergen
EP1150713B1 (en) Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
JP2747435B2 (ja) 肺炎球菌抗原の経鼻投与方法
Abraham et al. Oral immunization with bacterial polysaccharide and adjuvant enhances antigen-specific pulmonary secretory antibody response and resistance to pneumonia
VanCott et al. Induction of pneumococcal polysaccharide-specific mucosal immune responses by oral immunization
US6749831B1 (en) Vaccine against lipopolysaccharide core
EP0471954A2 (en) Immunogenic conjugates of nontoxic oligosaccharide derived from bordetella pertussis lipooligosaccharide
JPH06507420A (ja) 粘膜の病原体に対するワクチンとその製法
JPH11240844A (ja) 肺炎球菌抗原の経口投与
EP1011440A1 (en) Vaccine against lipopolysaccharide core
Massó et al. Specific serological response by active immunization with GD3-bearing liposomes.
Latil et al. Appearance of specific antibody-bearing cells in human bronchial mucosa after local immunization with bacterial vaccine